Janney Montgomery Scott LLC Beam Therapeutics Inc. Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
SELL
$39.79 - $70.31 $175,314 - $309,785
-4,406 Reduced 34.65%
8,308 $396,000
Q2 2022

Aug 03, 2022
BUY
$29.86 - $62.36 $19,946 - $41,656
668 Added 5.55%
12,714 $514,000
Q1 2022

May 04, 2022
BUY
$53.73 - $82.16 $448,108 - $685,214
8,340 Added 225.04%
12,046 $690,000
Q4 2021

Jan 27, 2022
SELL
$68.02 - $99.06 $196,237 - $285,788
-2,885 Reduced 43.77%
3,706 $295,000
Q3 2021

Oct 29, 2021
BUY
$84.37 - $133.6 $556,082 - $880,557
6,591 New
6,591 $573,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email